A new trading day began on November 20, 2023, with vTv Therapeutics Inc (NASDAQ: VTVT) stock priced at $15.20, down -5.71% from the previous day of trading. During the day, the shares moved up to $15.20 and dropped to $14.00 before settling in for the closing price of $0.37. VTVT’s price has ranged from $0.35 to $1.05 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 827.99%. With a float of $26.64 million, this company’s outstanding shares have now reached $81.48 million.
Let’s determine the extent of company efficiency that accounts for 13 employees. In terms of profitability, gross margin is +95.44, operating margin of -1116.95, and the pretax margin is -1232.56.
vTv Therapeutics Inc (VTVT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of vTv Therapeutics Inc is 67.31%, while institutional ownership is 2.22%. The most recent insider transaction that took place on Nov 29, was worth 33,773. In this transaction Director of this company bought 40,461 shares at a rate of $0.83, taking the stock ownership to the 61,000 shares. Before that another transaction happened on Nov 28, when Company’s Director bought 20,539 for $0.83, making the entire transaction worth $16,969. This insider now owns 20,539 shares in total.
vTv Therapeutics Inc (VTVT) Recent Fiscal highlights
In its latest quarterly report, released on 3/30/2023, the company reported earnings of -$0.06 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -949.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
vTv Therapeutics Inc (NASDAQ: VTVT) Trading Performance Indicators
Here are vTv Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2851.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26
Technical Analysis of vTv Therapeutics Inc (VTVT)
Looking closely at vTv Therapeutics Inc (NASDAQ: VTVT), its last 5-days average volume was 0.21 million, which is a jump from its year-to-date volume of 0.13 million. As of the previous 9 days, the stock’s Stochastic %D was 20.44%. Additionally, its Average True Range was 0.03.
During the past 100 days, vTv Therapeutics Inc’s (VTVT) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.17% in the past 14 days, which was lower than the 61.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4325, while its 200-day Moving Average is $0.6754. However, in the short run, vTv Therapeutics Inc’s stock first resistance to watch stands at $0.3700. Second resistance stands at $0.3900. The third major resistance level sits at $0.4000. If the price goes on to break the first support level at $0.3400, it is likely to go to the next support level at $0.3300. Now, if the price goes above the second support level, the third support stands at $0.3100.
vTv Therapeutics Inc (NASDAQ: VTVT) Key Stats
With a market capitalization of 28.52 million, the company has a total of 104,577K Shares Outstanding. Currently, annual sales are 2,020 K while annual income is -19,160 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,650 K.